ICH (International Conference on Harmonization) is an international conference that aims to harmonize the technical requirements of countries in the registration of medicines. Its full English name is International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, and Chinese is usually translated as "International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use".
The origins of the ICH can be traced back to 1990, and it was jointly initiated by the European Union, the United States and Japan, and was composed of the drug administrations and pharmaceutical enterprise authorities of the tripartite member states. In addition, Member States of the World Health Organization, as well as Canada and Sweden, participated as observers. The purpose of the ICH is to harmonize the technical requirements for drug registration in various countries, including harmonized standards, testing requirements, data collection and reporting formats, etc., so that pharmaceutical companies can apply for the registration of their drugs on a global scale. By achieving the ICH goal, pharmaceutical companies can launch their products in countries around the world at the same time, improve the quality of registration materials, shorten the research and development time, save expenses, and improve the efficiency of new drug research and development, registration and marketing.
Over the past few decades, ICH has successfully harmonized the technical requirements for drug registration in various countries, making it faster and easier for drugs to be approved and marketed worldwide. The results of the ICH will not only help improve the efficiency of drug research and development, but also help to protect the health and safety of the public.
For more information about ICH, it is advisable to consult the relevant literature or consult a pharmaceutical industry professional.
Materials** on the Internet.